ENDRA Life Sciences (NDRA) Operating Leases: 2019-2021
Historic Operating Leases for ENDRA Life Sciences (NDRA) over the last 2 years, with Dec 2021 value amounting to -$30,049.
- ENDRA Life Sciences' Operating Leases fell 91.09% to -$30,049 in Q4 2021 from the same period last year, while for Dec 2021 it was $650,477, marking a year-over-year change of. This contributed to the annual value of $518,147 for FY2022, which is 20.34% down from last year.
- According to the latest figures from Q4 2021, ENDRA Life Sciences' Operating Leases is -$30,049, which was down 4.12% from -$28,859 recorded in Q3 2021.
- ENDRA Life Sciences' Operating Leases' 5-year high stood at $424,210 during Q3 2019, with a 5-year trough of -$30,049 in Q4 2021.
- Over the past 3 years, ENDRA Life Sciences' median Operating Leases value was $370,989 (recorded in 2020), while the average stood at $260,594.
- Data for ENDRA Life Sciences' Operating Leases shows a maximum YoY slumped of 107.93% (in 2021) over the last 5 years.
- Over the past 3 years, ENDRA Life Sciences' Operating Leases (Quarterly) stood at $409,005 in 2019, then plummeted by 103.84% to -$15,725 in 2020, then plummeted by 91.09% to -$30,049 in 2021.
- Its Operating Leases stands at -$30,049 for Q4 2021, versus -$28,859 for Q3 2021 and $377,865 for Q2 2021.